Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
Nik Krajnc(Comprehensive Cancer Center Vienna), Gabriel Bsteh(Medical University of Vienna), Bianca Itariu(University of Vienna), Berthold Pemp(Medical University of Vienna), Christian Wöber(Medical University of Vienna), Wolfgang Marik(Medical University of Vienna), Stefan Macher(Medical University of Vienna), Martin Michl(Medical University of Vienna), Klaus Novak(University of Vienna), Jürgen Harreiter(Salzburger Landeskliniken)
Cited by 9
Related Papers
Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review
|Diabetic Medicine|2011|355
Long-chain n−3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial
|American Journal of Clinical Nutrition|2012|227
Impaired Local Production of Proresolving Lipid Mediators in Obesity and 17-HDHA as a Potential Treatment for Obesity-Associated Inflammation
|Diabetes|2013|227
Effect of physical activity and/or healthy eating on GDM risk: The DALI Lifestyle Study
|The Journal of Clinical Endocrinology & Metabolism|2016|224